Cargando…
Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
Autores principales: | Rachubinski, Angela L., Estrada, Belinda Enriquez, Norris, David, Dunnick, Cory A., Boldrick, Jennifer C., Espinosa, Joaquin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453941/ https://www.ncbi.nlm.nih.gov/pubmed/31008170 http://dx.doi.org/10.1016/j.jdcr.2019.02.007 |
Ejemplares similares
-
Role of janus kinase inhibitors in the treatment of alopecia areata
por: Triyangkulsri, Korn, et al.
Publicado: (2018) -
Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
por: Blume-Peytavi, Ulrike, et al.
Publicado: (2015) -
Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
por: Papierzewska, Małgorzata, et al.
Publicado: (2023) -
Janus Kinase Inhibitors for Alopecia Areata: A Systematic Review and Meta-Analysis
por: Liu, Ming, et al.
Publicado: (2023) -
At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
por: Yale, Katerina, et al.
Publicado: (2020)